000			01910 a2200529 4500
005			20250513100037.0
264		0	_c19961209
008			199612s 0 0 eng d
022			_a0883-5896
040			_aNLM _beng _cNLM
100	1		_aVarner, J A
245	0	0	_aTumor angiogenesis and the role of vascular cell integrin alphavbeta3. _h[electronic resource]
260			_bImportant advances in oncology _c1996
300			_a69-87 p. _bdigital
500			_aPublication Type: Journal Article; Review
650	0	4	_aAdult
650	0	4	_aAnimals
650	0	4	_aAntineoplastic Agents _xpharmacology
650	0	4	_aApoptosis _xphysiology
650	0	4	_aCell Adhesion Molecules _xphysiology
650	0	4	_aCell Transformation, Neoplastic
650	0	4	_aChild
650	0	4	_aClinical Trials, Phase II as Topic
650	0	4	_aEndothelial Growth Factors _xphysiology
650	0	4	_aExtracellular Matrix Proteins _xphysiology
650	0	4	_aEye Diseases _xphysiopathology
650	0	4	_aFemale
650	0	4	_aFibroblast Growth Factors _xphysiology
650	0	4	_aHumans
650	0	4	_aInflammation _xphysiopathology
650	0	4	_aLymphokines _xphysiology
650	0	4	_aMale
650	0	4	_aMetalloendopeptidases _xphysiology
650	0	4	_aNeoplasm Proteins _xphysiology
650	0	4	_aNeoplasms _xblood supply
650	0	4	_aNeovascularization, Pathologic _xprevention & control
650	0	4	_aOligopeptides _xphysiology
650	0	4	_aReceptor Protein-Tyrosine Kinases _xphysiology
650	0	4	_aReceptors, Fibroblast Growth Factor _xphysiology
650	0	4	_aReceptors, Growth Factor _xphysiology
650	0	4	_aReceptors, Vascular Endothelial Growth Factor
650	0	4	_aReceptors, Vitronectin _xphysiology
650	0	4	_aVascular Endothelial Growth Factor A
650	0	4	_aVascular Endothelial Growth Factors
700	1		_aCheresh, D A
773	0		_tImportant advances in oncology _gp. 69-87
999			_c8787683 _d8787683